Financial Statements — ACTU
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Cash & Equivalents | 8.13 | 16.92 | 6.49 | 3.89 | 13.52 | 0.35 |
| Total Current Assets | 8.52 | 17.44 | 6.69 | 4.25 | 14.26 | 0.55 |
| Total Non-current Assets* | 0.39 | 0.27 | 0.28 | 0.23 | 0.00 | 1.18 |
| Total Assets | 8.91 | 17.71 | 6.97 | 4.48 | 14.26 | 1.73 |
| Accounts Payable | 1.20 | 1.25 | 3.17 | 2.64 | 2.33 | 5.89 |
| Total Current Liabilities | 4.72 | 6.37 | 9.20 | 9.15 | 8.50 | 20.07 |
| Total Non-current Liabilities | 0.40 | 0.40 | 0.42 | 0.42 | 0.41 | 1.74 |
| Total Liabilities | 5.13 | 6.78 | 9.62 | 9.57 | 8.90 | 21.81 |
| Retained Earnings | (160.23) | (150.05) | (144.65) | (138.70) | (125.93) | (119.96) |
| Total Stockholder Equity | 3.78 | 10.94 | (2.65) | (5.09) | 5.36 | (114.26) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Research & Development | 2.57 | 2.13 | 2.18 | 2.76 | 3.22 | 3.69 | 3.76 | 4.37 |
| Selling, General & Admin | 3.14 | 2.56 | 3.29 | 3.20 | 3.15 | 2.87 | 1.64 | 1.06 |
| Total Operating Expenses | 5.71 | 4.69 | 5.47 | 5.97 | 6.37 | 6.56 | 5.39 | 5.44 |
| Operating Income | (5.71) | (4.69) | (5.47) | (5.97) | (6.37) | (6.56) | (5.39) | (5.44) |
| Net Income | (5.63) | (4.55) | (5.41) | (5.95) | (6.32) | (6.45) | (5.97) | (6.57) |
| Basic EPS | (0.24) | (0.19) | (0.25) | (0.30) | (0.32) | 1.22 | (0.55) | (4.20) |
| Diluted EPS | (0.24) | (0.19) | (0.25) | (0.30) | (0.32) | 1.22 | (0.55) | (4.20) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Operating Cash Flow | (5.02) | (3.74) | (6.68) | (4.17) | (4.62) | (4.77) | (9.15) | (7.92) |
| Financing Cash Flow | (0.01) | (0.03) | 17.11 | 6.78 | (0.13) | (0.11) | 22.32 | 5.31 |
